CHRISTIN L. HERTZ

PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes

Vanita R. Aroda, Julio Rosenstock, Yasuo Terauchi et al. · Diabetes Care · 2019 · 468 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial

Thomas R. Pieber, Bruce W. Bode, Young Min Cho et al. · The Lancet Diabetes & Endocrinology · 2019 · 274 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes

Rune Viig Overgaard, CHRISTIN L. HERTZ, Steen H. Ingwersen et al. · Cell Reports Medicine · 2021 · 100 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Genetic investigations of sudden unexpected deaths in infancy using next-generation sequencing of 100 genes associated with cardiac diseases

CHRISTIN L. HERTZ, Sofie Lindgren Christiansen, Maiken Kudahl Larsen et al. · European Journal of Human Genetics · 2015 · 66 citations · Full text

Medicine, Genetics, Molecular Genetics +16

Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases

CHRISTIN L. HERTZ, Sofie Lindgren Christiansen, Laura Ferrero‐Miliani et al. · International Journal of Legal Medicine · 2014 · 65 citations

Medicine, Cardiology, Genetics +16